HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.

AbstractBACKGROUND:
An elevated plasma homocysteine (Hcy) level has been prospectively associated with an increased risk of vascular and degenerative dementias. An Hcy elevation is prevalent in patients with Parkinson disease (PD) in part because levodopa metabolism produces Hcy. The clinical relevance of an elevated Hcy level in patients with PD is unknown.
OBJECTIVE:
To determine if hyperhomocysteinemia in patients with PD is associated with depression or with cognitive or physical impairments.
DESIGN:
Ninety-seven people with a mean (SD) PD duration of 3.6 (1.6) years completed the Beck Depression Inventory, a battery of 11 cognitive tests, and the motor and function components of the Unified Parkinson's Disease Rating Scale. Normalized scores for the affective, cognitive, and physical measures were compared between those with a normal Hcy level (n = 66) and those with hyperhomocysteinemia (n = 31) (Hcy level, >1.89 mg/L [>14 micro mol/L]), controlling for age, sex, disease duration, and treatment.
RESULTS:
Subjects with an elevated Hcy level were slightly older (68 vs 62 years), but had similar plasma concentrations of vitamin B(12) and folate. Hyperhomocysteinemic patients were more depressed (P =.02) and had worse cognition (P<.01), but the physical measure did not differ.
CONCLUSIONS:
Patients with PD and hyperhomocysteinemia are more likely to be depressed and to perform worse on neuropsychometric tasks compared with normohomocysteinemic patients. Further research is warranted to see if hyperhomocysteinemia is a reversible risk factor for neuropsychiatric burden in patients with PD.
AuthorsPadraig E O'Suilleabhain, Victor Sung, Carlos Hernandez, Laura Lacritz, Richard B Dewey Jr, Teodoro Bottiglieri, Ramon Diaz-Arrastia
JournalArchives of neurology (Arch Neurol) Vol. 61 Issue 6 Pg. 865-8 (Jun 2004) ISSN: 0003-9942 [Print] United States
PMID15210523 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Homocysteine
Topics
  • Aged
  • Cognition Disorders (blood, psychology)
  • Depression (blood, psychology)
  • Female
  • Homocysteine (blood)
  • Humans
  • Male
  • Middle Aged
  • Mood Disorders (blood, psychology)
  • Motor Skills Disorders (blood, psychology)
  • Parkinson Disease (blood, psychology)
  • Prospective Studies
  • Psychiatric Status Rating Scales (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: